1. Eli Lilly's stock is overvalued with a price/book ratio of 63.94 compared to the sector median of 2.47; 2. Despite strong revenue and earnings growth, the P/E and forward P/E ratios suggest extreme optimism in the stock pricing; 3. The company's dividend yield of 0.57% is below the sector median, indicating a need for higher returns to attract income investors.